Hjem › Kronisk nyresygdom › Tennessee
Kronisk nyresygdom kliniske forsøg i Tennessee
14 studier for Kronisk nyresygdom søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #4, Chattanooga
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Chattanooga
- Research Site, Knoxville
- Research Site, Knoxville
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Chattanooga
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 24. sep. 2026 · NCT07624305Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- University of Tennessee Health Science Center- Le Bonheur Research Center, Memphis
RekruttererFase 3
Alder 2 til 18 · Alle køn · Opdateret 21. sep. 2026 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Vanderbilt University Medical Center, Nashville
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 16. sep. 2026 · NCT07107945Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Southeast Renal Research Institute, Chattanooga
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2026 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Morristown
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07753993Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Memphis VA Medical Center, Memphis, TN, Memphis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05465044Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Knoxville Kidney Center Pllc, Brentwood
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 17. aug. 2026 · NCT06858319Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- Vanderbilt University Medical Center, Nashville
RekruttererFase 2
Alder 21 til 85 · Alle køn · Opdateret 6. maj 2026 · NCT04984226Empagliflozin Treatment in Kidney Transplant Recipients
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
RekruttererFase 4
Alder 19 og opefter · Alle køn · Opdateret 21. apr. 2026 · NCT06013865Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 6. apr. 2026 · NCT07385651SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- James Eric Gardner, MD, PC, Memphis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06001827Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jan. 2026 · NCT06374277Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.